These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20201838)

  • 1. Corticotropin-releasing hormone-receptor 2 is required for acute stress-induced bladder vascular permeability and release of vascular endothelial growth factor.
    Boucher W; Kempuraj D; Michaelian M; Theoharides TC
    BJU Int; 2010 Nov; 106(9):1394-9. PubMed ID: 20201838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute stress and intravesical corticotropin-releasing hormone induces mast cell dependent vascular endothelial growth factor release from mouse bladder explants.
    Cao J; Boucher W; Kempuraj D; Donelan JM; Theoharides TC
    J Urol; 2006 Sep; 176(3):1208-13. PubMed ID: 16890727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical suplatast tosilate (IPD-1151T) inhibits experimental bladder inflammation.
    Boucher W; Kempuraj D; Cao J; Papaliodis D; Theoharides TC
    J Urol; 2007 Mar; 177(3):1186-90. PubMed ID: 17296442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors.
    Singh LK; Boucher W; Pang X; Letourneau R; Seretakis D; Green M; Theoharides TC
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1349-56. PubMed ID: 10027877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of corticotropin-releasing hormone (CRH) on endothelin-1 and NO release, mediated by CRH receptor subtype R2: a potential link between stress and endothelial dysfunction?
    Wilbert-Lampen U; Trapp A; Modrzik M; Fiedler B; Straube F; Plasse A
    J Psychosom Res; 2006 Oct; 61(4):453-60. PubMed ID: 17011352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor.
    Cao J; Papadopoulou N; Kempuraj D; Boucher WS; Sugimoto K; Cetrulo CL; Theoharides TC
    J Immunol; 2005 Jun; 174(12):7665-75. PubMed ID: 15944267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing hormone (CRH) regulates macromolecular permeability via mast cells in normal human colonic biopsies in vitro.
    Wallon C; Yang PC; Keita AV; Ericson AC; McKay DM; Sherman PM; Perdue MH; Söderholm JD
    Gut; 2008 Jan; 57(1):50-8. PubMed ID: 17525093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects.
    Theoharides TC; Singh LK; Boucher W; Pang X; Letourneau R; Webster E; Chrousos G
    Endocrinology; 1998 Jan; 139(1):403-13. PubMed ID: 9421440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of corticotropin-releasing hormone receptor-2 expression in human cord blood-derived cultured mast cells.
    Papadopoulou NG; Oleson L; Kempuraj D; Donelan J; Cetrulo CL; Theoharides TC
    J Mol Endocrinol; 2005 Dec; 35(3):R1-8. PubMed ID: 16326828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress-induced barrier disruption of rat follicle-associated epithelium involves corticotropin-releasing hormone, acetylcholine, substance P, and mast cells.
    Keita AV; Söderholm JD; Ericson AC
    Neurogastroenterol Motil; 2010 Jul; 22(7):770-8, e221-2. PubMed ID: 20149111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress.
    Esposito P; Chandler N; Kandere K; Basu S; Jacobson S; Connolly R; Tutor D; Theoharides TC
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1061-6. PubMed ID: 12438528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing hormone attenuates vascular endothelial growth factor release from human HaCaT keratinocytes.
    Zhou CL; Yu XJ; Chen LM; Jiang H; Li CY
    Regul Pept; 2010 Feb; 160(1-3):115-20. PubMed ID: 19852986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotropin-releasing hormone signaling in synovial tissue from patients with early inflammatory arthritis is mediated by the type 1 alpha corticotropin-releasing hormone receptor.
    McEvoy AN; Bresnihan B; FitzGerald O; Murphy EP
    Arthritis Rheum; 2001 Aug; 44(8):1761-7. PubMed ID: 11508426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amygdaloid pERK1/2 in corticotropin-releasing hormone overexpressing mice under basal and acute stress conditions.
    Silberstein S; Vogl AM; Refojo D; Senin SA; Wurst W; Holsboer F; Deussing JM; Arzt E
    Neuroscience; 2009 Mar; 159(2):610-7. PubMed ID: 19361479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redistribution of corticotropin-releasing hormone receptor R2 using fluorescence immunohistochemistry in fetal membranes of women delivering preterm or at term.
    Jirecek S; Tringler B; Knöfler M; Bauer S; Topcuoglu A; Egarter C
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):1008-12. PubMed ID: 12635470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute stress results in skin corticotropin-releasing hormone secretion, mast cell activation and vascular permeability, an effect mimicked by intradermal corticotropin-releasing hormone and inhibited by histamine-1 receptor antagonists.
    Lytinas M; Kempuraj D; Huang M; Boucher W; Esposito P; Theoharides TC
    Int Arch Allergy Immunol; 2003 Mar; 130(3):224-31. PubMed ID: 12660427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditional mouse mutants highlight mechanisms of corticotropin-releasing hormone effects on stress-coping behavior.
    Lu A; Steiner MA; Whittle N; Vogl AM; Walser SM; Ableitner M; Refojo D; Ekker M; Rubenstein JL; Stalla GK; Singewald N; Holsboer F; Wotjak CT; Wurst W; Deussing JM
    Mol Psychiatry; 2008 Nov; 13(11):1028-42. PubMed ID: 18475271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotropin releasing hormone receptor alterations elicited by acute and chronic unpredictable stressor challenges in stressor-susceptible and resilient strains of mice.
    Anisman H; Prakash P; Merali Z; Poulter MO
    Behav Brain Res; 2007 Aug; 181(2):180-90. PubMed ID: 17517441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of corticotropin-releasing hormone and receptor in the pathogenesis of psoriasis.
    Zhou C; Yu X; Cai D; Liu C; Li C
    Med Hypotheses; 2009 Oct; 73(4):513-5. PubMed ID: 19560286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of corticotropin-releasing hormone type-2 receptor alters sleep responses to bacterial lipopolysaccharide in mice.
    Jakubcakova V; Flachskamm C; Deussing JM; Kimura M
    Brain Behav Immun; 2011 Nov; 25(8):1626-36. PubMed ID: 21704697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.